임상 한눈에 보기

• 17건의 ClinicalTrials.gov 임상 기록
• Phase·Status 요약은 enrollment 상위 표본 기준입니다
• 임상시험 탭에서 enrollment 상위 목록을 불러올 수 있습니다
• Phase: Phase 1, Phase 2 · Phase 1 · Phase 2 · Phase 3
• Status: Terminated · Completed · Active, not recruiting
• 주요 endpoint: Phase 1b Lead-in: Number of Participants With First 2 Cycles Dose Limiting Toxicity (DLT) for Combination A · Phase 1b Lead-in: Number of Participants With First 2 Cycles DLT for Combination B · Phase 1b Lead-in: Number of Participants With First 2 Cycles DLT for Combination C · Phase 1b Lead-in: Number of Participants With First 2 Cycles DLT for Combination D · Phase 1b Lead-in: Number of Participants With First Cycle DLT for Combination F
• 선택한 코호트 보고값: ORR 67%
• 핵심: The primary objectives of this study are: Phase 1: To evaluate the safety of axicabtagene ciloleucel in combination wit…

임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.

수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다. 효능 수치는 선택한 등록 결과이며 전적응증 값이 아닙니다.